STRAGEN
LIVE

Serial Number

79121314

Owner

Stragen Pharma S.A.

Filing Date

Oct 9, 2012

Add to watchlist:

No watchlists yet
View on USPTO

STRAGEN Trademark

Serial Number: 79121314 • Registration: 4449450

STRAGEN is a trademark filed by Stragen Pharma S.A. on October 9, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Stragen Pharma S.A. (10 trademarks)

Chemin du Pré-Fleuri 3

Entity Type: 03

Trademark Details

Filing Date

October 9, 2012

Registration Date

December 17, 2013

Published for Opposition

October 1, 2013

Cancellation Date

February 26, 2021

Goods & Services

Pharmaceutical preparations and substances, namely, antibiotics, anticonvulsants, antiepileptic preparations and substances for the treatment of cardiological diseases, bone diseases, oncology, gynecology, rhumatology, phlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary use

Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical research, testing, trials and finalization of pharmaceutical products, medical devices and biotechnology

Chemical preparations for industrial and scientific use, including for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary use; chemical substances, namely, reagents for chemical analysis in laboratories

Regulatory compliance consultancy in the field of pharmaceutical products, medical devices and biotechnology products

Consultancy in the field of medical treatments and advice in the pharmaceutical field

Consulting in the field of pharmaceutical science; research, design and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for others, namely, monitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial research, testing and evaluation of pharmaceutical products, medical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical products, medical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparations, remedies and medicines; technological services, namely, scientific research, analysis and testing in the pharmaceutical and health care sector; scientific research and analysis, namely, conducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and development, namely, conducting clinical trials of medicines of others; product development in the field of medicine

Filing History

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 7, 2023 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 11, 2023 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 5, 2023 FINP
GENERIC MADRID TRANSACTION SENT TO IB
Jan 11, 2023 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 11, 2023 INNA
GENERIC MADRID TRANSACTION CREATED
Jan 11, 2023 XXCR
INTERNATIONAL REGISTRATION RENEWED
Nov 1, 2022 RNWL
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
May 8, 2020 FINV
NEW REPRESENTATIVE AT IB RECEIVED
Mar 15, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 9, 2014 FICS
FINAL DISPOSITION PROCESSED
May 9, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2013 R.PR
PUBLISHED FOR OPPOSITION
Oct 1, 2013 PUBO
NOTIFICATION PROCESSED BY IB
Sep 30, 2013 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 11, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 11, 2013 OP2R
NOTICE OF PUBLICATION
Sep 11, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 27, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2013 CRFA
ASSIGNED TO LIE
Aug 16, 2013 ALIE
NOTICE OF REVIVAL - MAILED
Aug 14, 2013 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2013 TROA
PETITION TO REVIVE-GRANTED
Aug 14, 2013 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 14, 2013 PROA
ATTORNEY REVIEW COMPLETED
May 10, 2013 ATRV
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
May 10, 2013 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Apr 20, 2013 LIMG
REFUSAL PROCESSED BY IB
Feb 27, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2013 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 5, 2013 RFCR
NON-FINAL ACTION WRITTEN
Feb 4, 2013 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 18, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2012 REPR